Eli Lilly & Co. (LLY)
1142.64
-16.96
(-1.46%)
USD |
NYSE |
Sep 04, 10:31
Eli Lilly Cash and Short Term Investments (Annual) : 7.268B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.268B |
| December 31, 2024 | 3.423B |
| December 31, 2023 | 2.928B |
| December 31, 2022 | 2.212B |
| December 31, 2021 | 3.909B |
| December 31, 2020 | 3.681B |
| December 31, 2019 | 2.438B |
| December 31, 2018 | 7.409B |
| December 31, 2017 | 8.034B |
| December 31, 2016 | 6.039B |
| December 31, 2015 | 4.452B |
| December 31, 2014 | 4.827B |
| December 31, 2013 | 5.397B |
| December 31, 2012 | 5.684B |
| December 31, 2011 | 6.897B |
| December 31, 2010 | 6.727B |
| December 31, 2009 | 4.498B |
| December 31, 2008 | 5.926B |
| December 31, 2007 | 4.831B |
| December 31, 2006 | 3.891B |
| December 31, 2005 | 5.038B |
| December 31, 2004 | 7.464B |
| December 31, 2003 | 3.713B |
| Date | Value |
|---|---|
| December 31, 2002 | 3.655B |
| December 31, 2001 | 3.731B |
| December 31, 2000 | 4.618B |
| December 31, 1999 | 3.836B |
| December 31, 1998 | 1.597B |
| December 31, 1997 | 2.025B |
| December 31, 1996 | 955.10M |
| December 31, 1995 | 1.084B |
| December 31, 1994 | 746.70M |
| December 31, 1993 | 987.10M |
| December 31, 1992 | 728.30M |
| December 31, 1991 | 782.40M |
| December 31, 1990 | 750.80M |
| December 31, 1989 | 652.00M |
| December 31, 1988 | 761.50M |
| December 31, 1987 | 1.031B |
| December 31, 1986 | 486.00M |
| December 31, 1985 | 406.10M |
| December 31, 1984 | 445.30M |
| December 31, 1983 | 491.00M |
| December 31, 1982 | 303.75M |
| December 31, 1981 | 262.70M |
| December 31, 1980 | 202.35M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Johnson & Johnson | 20.10B |
| Merck & Co., Inc. | 14.69B |
| Pfizer Inc. | 13.60B |
| Bristol Myers Squibb Co. | 10.67B |
| Atai Beckley, Inc. | 256.04M |